12/4
07:03 pm
veru
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop [Yahoo! Finance]
Medium
Report
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop [Yahoo! Finance]
12/4
08:30 am
veru
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
Medium
Report
Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
11/17
02:54 pm
veru
Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight [Yahoo! Finance]
Low
Report
Global Contraceptive Devices Market is Set to Accelerate at a CAGR of ~6% by 2032, as Demand for Advanced Birth Control Solutions Rises | DelveInsight [Yahoo! Finance]
10/31
08:30 am
veru
Veru to Present Two Abstracts at ObesityWeek 2025
Low
Report
Veru to Present Two Abstracts at ObesityWeek 2025
10/30
08:00 am
veru
Veru Announces Pricing of $25 Million Public Offering
Medium
Report
Veru Announces Pricing of $25 Million Public Offering
10/29
04:01 pm
veru
Veru Announces Proposed Public Offering
High
Report
Veru Announces Proposed Public Offering
9/27
08:45 am
veru
Onconetix announces financing through private placement, debt settlement [Yahoo! Finance]
Low
Report
Onconetix announces financing through private placement, debt settlement [Yahoo! Finance]
9/26
08:44 am
veru
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. [Yahoo! Finance]
Medium
Report
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc. [Yahoo! Finance]
9/23
09:00 am
veru
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity [Yahoo! Finance]
Low
Report
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity [Yahoo! Finance]
9/23
08:30 am
veru
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
Medium
Report
Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity